Hepatitis B induced by hepatitis B virus (HBV) remains a major public health problem
worldwide. Although several antiviral drugs have been approved for hepatitis B, they cause …

Since the significant public health hazard of Hepatitis B virus (HBV) infection and obvious
drug resistance and dose-dependent side effects for common antiviral agents (eg …

Hepatitis B virus (HBV) or hepatitis C virus (HCV) infections are a major threat worldwide.
Combination therapy of interferon-α and ribavirin is currently the treatment of choice for HCV …

There are 350,000 hepatitis B virus (HBV) carriers all over the world. Chronic HBV infection
is at a high risk of developing liver cirrhosis and hepatocelluar carcinoma (HCC), and …

Despite that some approved drugs and genetically engineered vaccines against hepatitis B
virus (HBV) are available for HBV patients, HBV infection is still a severe public health …

Hepatitis B virus (HBV) is inherently a hepatotropic virus that causes acute and chronic
hepatitis in about one-third of world population. Of the estimated 360 million chronically …

Traditional Chinese herbal medicine (TCHM) has been widely used in the treatment of
chronic hepatitis B (CHB) in C hina. The systematic analysis of clinical research of TCHM …

Background Hepatitis B virus infection is a serious health problem worldwide. Traditional
Chinese medicinal herbs have been widely used to treat chronic liver diseases, and many …

Current treatments against chronic hepatitis B (CHB) include pegylated interferon alpha
(Peg‐IFNα) and nucleos (t) ide analogs (NAs), the latter targeting the viral retrotranscriptase …

Abstract Ethnopharmacological relevance Yin-Chen is a famous traditional Chinese
medicine (TCM) in China for the treatment of acute and chronic hepatitis. Two species …